Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.

Saved in:
Bibliographic Details
Title: Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.
Authors: Falkson CI; Department of Medical Oncology, University of Pretoria, Republic of South Africa. cfalkson@medic.up.ac.za, Cohen GL
Source: Oncology [Oncology] 1998 Mar-Apr; Vol. 55 (2), pp. 116-21.
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0030-2414
DOI:10.1159/000011845